Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (71)	8/5/1999 6:42:00 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 360

Second quarter results biz.yahoo.com A couple cents better than the forecast...but more importantly, no surprises and confusion like last time. During the second half of 1999, we anticipate signing up one or more new target discovery customers, are planning to launch the initial GeneExpress products, and are seeking to enter a partnership for development of the Flow-thru Chip. I expect such initiatives, combined with payments from our existing customers, to reduce our burn rate. So I wonder if that means that the chip is meeting expectations and they need a partner to ramp up production? During the second quarter, the company scaled up the collection and analysis of tissues and believes it now has one of the highest-throughput gene expression operations in the world.